One in ten women have endometriosis, yet most aren’t diagnosed until they’re struggling to get pregnant or can no longer live with the pain. In this episode, Ellen Scanlon shares her personal story of navigating pain, infertility, and finally a diagnosis of endometriosis with biotech entrepreneur Caitlyn Krebs, CEO of Nalu Bio. They talk about this chronic and often invisible disease and what the future of treatment could look like. If you’ve ever felt dismissed or misunderstood when it comes to period pain or infertility, this episode is for you.
We cover:
- What endometriosis actually is and why diagnosis takes so long
- How cannabis and the endocannabinoid system are offering real relief
- Ellen’s personal story navigating pain, infertility, and finally a diagnosis
- The future of non-hormonal, non-opioid treatments for endo warriors
If you enjoyed this episode, we recommend Episode 283. Why More Women Are Choosing Weed Over Advil
Hosted by Ellen Scanlon
Sign up for Ellen’s newsletter on Substack at https://dothepot.substack.com/ or at dothepot.com
Spend the day with meld! While supplies last, Nalu Bio is offering free sample kits to How to Do the Pot listeners. Sign up for the meld newsletter at www.meldscience.com to claim your free kit and help shape the future of women’s health. Includes 3 no-high blends: Move Free, Stay Calm, and Sleep Well.
This is the app Caitlyn mentioned: Nezhat Endometriosis Advisor, which has an endometriosis risk score that is 94% predictive of endo.
https://apps.apple.com/us/app/nezhat-endometriosis-advisor/id1478526317
Follow on IG: @dothepot / FB: @dothepot / X: @dothepot